The Interaction Between Sleep and Metabolism in Alzheimer’s Disease: Cause or Consequence of Disease?

Caitlin M. Carroll; Shannon L. Macauley

doi:10.3389/fnagi.2019.00258

The Interaction Between Sleep and Metabolism in Alzheimer’s Disease: Cause or Consequence of Disease?

Caitlin M. Carroll, Shannon L. Macauley

Physiology

Research output: Contribution to journal › Review article › peer-review

13 Scopus citations

Abstract

Alzheimer’s disease (AD) is the most common form of dementia and affects over 45 million people worldwide. Both type-2-diabetes (T2D), a metabolic condition associated with aging, and disrupted sleep are implicated in the pathogenesis of AD, but how sleep and metabolism interact to affect AD progression remains unclear. In the healthy brain, sleep/wake cycles are a well-coordinated interaction between metabolic and neuronal activity, but when disrupted, are associated with a myriad of health-related issues, including metabolic syndrome, cardiovascular disease, T2D, and AD. Therefore, this review will explore our current understanding of the relationship between metabolism, sleep, and AD-related pathology to identify the causes and consequences of disease progression in AD. Moreover, sleep disturbances and metabolic dysfunction could serve as potential therapeutic targets to mitigate the increased risk of AD in individuals with T2D or offer a novel approach for treating AD.

Original language	English
Article number	258
Journal	Frontiers in Aging Neuroscience
Volume	11
DOIs	https://doi.org/10.3389/fnagi.2019.00258
State	Published - Sep 20 2019

Bibliographical note

Funding Information:
The authors would like to thank their colleagues for the careful review and critique of this manuscript. Funding. We would like to acknowledge the following grants: 1K01AG050719 (SM), R01AG061805 (SM), NCDRC Pilot Award (SM), and the Wake Forest University Alzheimer’s Disease Research Center (P30 AG049638), which is funded by the National Institute on Aging.

Publisher Copyright:
© Copyright © 2019 Carroll and Macauley.

Keywords

Alzheimer’s disease
glucose
insulin
metabolism
sleep
type-2-diabetes

ASJC Scopus subject areas

Aging
Cognitive Neuroscience

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3389/fnagi.2019.00258

Cite this

@article{46764147594f45839f5ff4dc621e8113,

title = "The Interaction Between Sleep and Metabolism in Alzheimer{\textquoteright}s Disease: Cause or Consequence of Disease?",

abstract = "Alzheimer{\textquoteright}s disease (AD) is the most common form of dementia and affects over 45 million people worldwide. Both type-2-diabetes (T2D), a metabolic condition associated with aging, and disrupted sleep are implicated in the pathogenesis of AD, but how sleep and metabolism interact to affect AD progression remains unclear. In the healthy brain, sleep/wake cycles are a well-coordinated interaction between metabolic and neuronal activity, but when disrupted, are associated with a myriad of health-related issues, including metabolic syndrome, cardiovascular disease, T2D, and AD. Therefore, this review will explore our current understanding of the relationship between metabolism, sleep, and AD-related pathology to identify the causes and consequences of disease progression in AD. Moreover, sleep disturbances and metabolic dysfunction could serve as potential therapeutic targets to mitigate the increased risk of AD in individuals with T2D or offer a novel approach for treating AD.",

keywords = "Alzheimer{\textquoteright}s disease, glucose, insulin, metabolism, sleep, type-2-diabetes",

author = "Carroll, {Caitlin M.} and Macauley, {Shannon L.}",

note = "Funding Information: The authors would like to thank their colleagues for the careful review and critique of this manuscript. Funding. We would like to acknowledge the following grants: 1K01AG050719 (SM), R01AG061805 (SM), NCDRC Pilot Award (SM), and the Wake Forest University Alzheimer{\textquoteright}s Disease Research Center (P30 AG049638), which is funded by the National Institute on Aging. Publisher Copyright: {\textcopyright} Copyright {\textcopyright} 2019 Carroll and Macauley.",

year = "2019",

month = sep,

day = "20",

doi = "10.3389/fnagi.2019.00258",

language = "English",

volume = "11",

}

TY - JOUR

T1 - The Interaction Between Sleep and Metabolism in Alzheimer’s Disease

T2 - Cause or Consequence of Disease?

AU - Carroll, Caitlin M.

AU - Macauley, Shannon L.

N1 - Funding Information: The authors would like to thank their colleagues for the careful review and critique of this manuscript. Funding. We would like to acknowledge the following grants: 1K01AG050719 (SM), R01AG061805 (SM), NCDRC Pilot Award (SM), and the Wake Forest University Alzheimer’s Disease Research Center (P30 AG049638), which is funded by the National Institute on Aging. Publisher Copyright: © Copyright © 2019 Carroll and Macauley.

PY - 2019/9/20

Y1 - 2019/9/20

N2 - Alzheimer’s disease (AD) is the most common form of dementia and affects over 45 million people worldwide. Both type-2-diabetes (T2D), a metabolic condition associated with aging, and disrupted sleep are implicated in the pathogenesis of AD, but how sleep and metabolism interact to affect AD progression remains unclear. In the healthy brain, sleep/wake cycles are a well-coordinated interaction between metabolic and neuronal activity, but when disrupted, are associated with a myriad of health-related issues, including metabolic syndrome, cardiovascular disease, T2D, and AD. Therefore, this review will explore our current understanding of the relationship between metabolism, sleep, and AD-related pathology to identify the causes and consequences of disease progression in AD. Moreover, sleep disturbances and metabolic dysfunction could serve as potential therapeutic targets to mitigate the increased risk of AD in individuals with T2D or offer a novel approach for treating AD.

AB - Alzheimer’s disease (AD) is the most common form of dementia and affects over 45 million people worldwide. Both type-2-diabetes (T2D), a metabolic condition associated with aging, and disrupted sleep are implicated in the pathogenesis of AD, but how sleep and metabolism interact to affect AD progression remains unclear. In the healthy brain, sleep/wake cycles are a well-coordinated interaction between metabolic and neuronal activity, but when disrupted, are associated with a myriad of health-related issues, including metabolic syndrome, cardiovascular disease, T2D, and AD. Therefore, this review will explore our current understanding of the relationship between metabolism, sleep, and AD-related pathology to identify the causes and consequences of disease progression in AD. Moreover, sleep disturbances and metabolic dysfunction could serve as potential therapeutic targets to mitigate the increased risk of AD in individuals with T2D or offer a novel approach for treating AD.

KW - Alzheimer’s disease

KW - glucose

KW - insulin

KW - metabolism

KW - sleep

KW - type-2-diabetes

UR - http://www.scopus.com/inward/record.url?scp=85072972346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072972346&partnerID=8YFLogxK

U2 - 10.3389/fnagi.2019.00258

DO - 10.3389/fnagi.2019.00258

M3 - Review article

AN - SCOPUS:85072972346

SN - 1663-4365

VL - 11

JO - Frontiers in Aging Neuroscience

JF - Frontiers in Aging Neuroscience

M1 - 258

ER -

The Interaction Between Sleep and Metabolism in Alzheimer’s Disease: Cause or Consequence of Disease?

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this